Stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030.
The major factors driving the growth of the market includes increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry. Increasing global burden of diseases such as diabetes, cancer, and others are projected to be the major factors leading to the market growth. According to the World Health Organization (WHO) in 2017, number of patients suffering from type I and type II diabetes was estimated to be over 422 million. Moreover, the disease is expected to be the seventh largest cause of death by 2030.
Major Key Players of the Stem Cell Therapy Market are:
Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l.JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc , and AlloSource
No comments:
Post a Comment